4-(3,4-DIMETHOXYPHENYL)-2-PHENYL-5,6,7,8-TETRAHYDRO-2H-PHTHALAZIN-1-ONE
Compound with spectra: 1 NMR
| SpectraBase Compound ID | 8V6ODOpzIaF |
|---|---|
| InChI | InChI=1S/C22H22N2O3/c1-26-19-13-12-15(14-20(19)27-2)21-17-10-6-7-11-18(17)22(25)24(23-21)16-8-4-3-5-9-16/h3-5,8-9,12-14H,6-7,10-11H2,1-2H3 |
| InChIKey | UNINBHSLMQMMCW-UHFFFAOYSA-N |
| Mol Weight | 362.43 g/mol |
| Molecular Formula | C22H22N2O3 |
| Exact Mass | 362.163043 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
1-[2-(4-Acetylphenylamino)acetyl]-4,5-dihydro-5-(2,4-dimethoxyphenyl)-3-(3,4-dimethoxyphenyl)-1H-pyrazole
1-O-BETA-D-(6'-O-GALLOYL)-GLUCOPYRANOSYL-3-METHOXY-5-HYDROXYBENZENE-PERACETYLATE
TAMADONE
1H-pyrazole-3-carboxamide, 4-[2-(3-butyl-5-chloro-2(3H)-benzoxazolylidene)ethylidene]-N-hexyl-4,5-dihydro-5-oxo-1-phenyl-
N-(1-adamantylmethyl)-5-(3,4-dimethoxyphenyl)-7-(trifluoromethyl)-2-pyrazolo[1,5-a]pyrimidinecarboxamide
(3aR,4S,9aR)-4-(3,5-dimethoxy-4-oxidanyl-phenyl)-7-oxidanyl-6-propan-2-yloxy-3a,4,9,9a-tetrahydro-1H-benzo[f][2]benzofuran-3-one
3-C-benzene-1-methyl-2-oxo-4-N-phenyl-1,2-dihydroquinoline-3,4-diamido
1-(4-amino-1,2,5-oxadiazol-3-yl)-N'-[(E)-(2-methoxy-1-naphthyl)methylidene]-5-[(methylanilino)methyl]-1H-1,2,3-triazole-4-carbohydrazide
3-[4-(4'-CHLOROBENZOYL)-AMINO-1,3-DIMETHYLPYRAZOL-5-YL]-5-METHOXYINDOLE
3-HYDROXY-5,6,7,8,4'-PENTAMETHOXYFLAVONE
| Title | Journal or Book | Year |
|---|---|---|
| Novel Selective PDE4 Inhibitors. 1. Synthesis, Structure−Activity Relationships, and Molecular Modeling of 4-(3,4-Dimethoxyphenyl)-2H-phthalazin-1-ones and Analogues | Journal of Medicinal Chemistry | 2001 |
This compound is available in the following databases:
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.